- Report
- September 2023
- 133 Pages
Asia Pacific
From €1335EUR$1,500USD£1,167GBP
- Report
- May 2024
- 188 Pages
Global
From €4407EUR$4,950USD£3,850GBP
- Report
- December 2023
- 1362 Pages
Global
From €8898EUR$9,995USD£7,775GBP
- Report
- November 2023
- 109 Pages
Middle East, Africa
From €2626EUR$2,950USD£2,295GBP
- Report
- April 2024
- 128 Pages
China
From €1602EUR$1,800USD£1,400GBP
- Report
- September 2024
- 96 Pages
Global
From €3500EUR$4,212USD£3,165GBP
- Report
- January 2024
- 103 Pages
Global
From €3500EUR$4,212USD£3,165GBP
- Report
- August 2023
- 108 Pages
Global
From €3500EUR$4,212USD£3,165GBP
- Report
- June 2023
- 92 Pages
Global
From €3500EUR$4,212USD£3,165GBP
- Report
- January 2025
- 132 Pages
Global
From €846EUR$950USD£739GBP
- Report
- March 2025
- 403 Pages
Global
From €2364EUR$2,655USD£2,065GBP
- Book
- October 2020
North America

The Extracorporeal Membrane Oxygenation (ECMO) Machine is a medical device used to provide life support to patients with severe respiratory or cardiac failure. It works by taking blood from the patient, oxygenating it, and then returning it to the patient. The ECMO Machine is used in a variety of clinical settings, including intensive care units, neonatal intensive care units, and emergency departments. It is also used in the treatment of acute respiratory distress syndrome, acute myocardial infarction, and other conditions.
The ECMO Machine market is a rapidly growing segment of the medical device industry. It is driven by the increasing prevalence of chronic diseases, the need for improved patient outcomes, and the development of new technologies. The market is expected to continue to grow in the coming years, as more healthcare providers adopt the technology.
Some of the major players in the ECMO Machine market include Medtronic, Sorin Group, Maquet, Getinge Group, and Nipro. Show Less Read more